Skip to Content

  • Search

View Additional Section Content

NCCTG - N0733 - PHASE II TRIAL OF CAPECITABINE AND LAPATINIB WITH OR WITHOUT IMC-A12 IN PATIENTS WITH HER2 POSITIVE BREAST CANCER PREVIOUSLY TREATED WITH TRASTUZUMAB AND ANTHRACYCLINE AND/OR TAXANE.

Objective

Clinical Trial Categories

  • Breast Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details